BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28651444)

  • 1. Novel treatment strategy for advanced hepatocellular carcinoma: combination of conventional transcatheter arterial chemoembolization and modified method with portal vein occlusion for cases with arterioportal shunt: a preliminary study.
    Yasui D; Murata S; Ueda T; Sugihara F; Onozawa S; Kawamoto C; Kumita S
    Acta Radiol; 2018 Mar; 59(3):266-274. PubMed ID: 28651444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter arterial chemoembolization of hepatocellular carcinoma with hepatic arteriovenous shunt after temporary balloon occlusion of hepatic vein.
    Lee JH; Won JH; Park SI; Won JY; Lee DY; Kang BC
    J Vasc Interv Radiol; 2007 Mar; 18(3):377-82. PubMed ID: 17377183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma invading the main portal vein: treatment with transcatheter arterial chemoembolization and portal vein stenting.
    Zhang XB; Wang JH; Yan ZP; Qian S; Liu R
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):52-61. PubMed ID: 18931871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis.
    Kim JH; Yoon HK; Kim SY; Kim KM; Ko GY; Gwon DI; Sung KB
    Aliment Pharmacol Ther; 2009 Jun; 29(12):1291-8. PubMed ID: 19392861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
    Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
    Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: a pilot study.
    Tan X; Xie P; Liu J; Wu H; Xie Y
    Asia Pac J Clin Oncol; 2015 Sep; 11(3):e6-e12. PubMed ID: 25228074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter arterial chemoembolization combined with radiofrequency ablation can improve survival of patients with hepatocellular carcinoma with portal vein tumour thrombosis: extending the indication for ablation?
    Zheng JS; Long J; Sun B; Lu NN; Fang D; Zhao LY; Du N
    Clin Radiol; 2014 Jun; 69(6):e253-63. PubMed ID: 24581962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.
    Kim JH; Yoon HK; Ko GY; Gwon DI; Jang CS; Song HY; Shin JH; Sung KB
    Radiology; 2010 Apr; 255(1):270-7. PubMed ID: 20308463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results.
    Lucatelli P; Ginnani Corradini L; De Rubeis G; Rocco B; Basilico F; Cannavale A; Nardis PG; Corona M; Saba L; Catalano C; Bezzi M
    Cardiovasc Intervent Radiol; 2019 Jun; 42(6):853-862. PubMed ID: 30843093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome and prognostic factors of spontaneous ruptured hepatocellular carcinoma treated with transarterial embolization.
    Shin BS; Park MH; Jeon GS
    Acta Radiol; 2011 Apr; 52(3):331-5. PubMed ID: 21498371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: a prospective study.
    Long J; Zheng JS; Sun B; Lu N
    Hepatol Int; 2016 Jan; 10(1):175-84. PubMed ID: 26742761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and efficacy of balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma refractory to conventional transcatheter arterial chemoembolization.
    Kim PH; Gwon DI; Kim JW; Chu HH; Kim JH
    Eur Radiol; 2020 Oct; 30(10):5650-5662. PubMed ID: 32409860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.
    Lee HS; Kim JS; Choi IJ; Chung JW; Park JH; Kim CY
    Cancer; 1997 Jun; 79(11):2087-94. PubMed ID: 9179054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].
    Wu DH; Chen LH
    Ai Zheng; 2004 Jul; 23(7):825-8. PubMed ID: 15248921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma.
    Ha Y; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS; Park SR; Ryu MH; Ryoo BY; Kang YK; Kim KM
    Oncotarget; 2016 Nov; 7(45):74303-74313. PubMed ID: 27494871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis.
    Zhang Y; Fan W; Wang Y; Lu L; Fu S; Yang J; Huang Y; Yao W; Li J
    Oncologist; 2015 Dec; 20(12):1417-24. PubMed ID: 26446238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrograde portal vein flow and transarterial chemoembolization in patients with hepatocellular carcinoma - a case-control study.
    Kirstein MM; Voigtländer T; Schweitzer N; Gebel M; Hinrichs JB; Rodt T; Manns MP; Wacker F; Potthoff A; Vogel A
    Scand J Gastroenterol; 2017 Dec; 52(12):1398-1406. PubMed ID: 28847187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which system is better to predict prognosis of patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization as initial therapy? Comparison between CLIP and JIS in a Japanese population.
    Urakawa H; Kora SI; Mitsufuji T; Osame A; Higahsihara H; Yoshimitsu K
    Acta Radiol; 2016 Dec; 57(12):1445-1452. PubMed ID: 26861204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus.
    Peng BG; He Q; Li JP; Zhou F
    Am J Surg; 2009 Sep; 198(3):313-8. PubMed ID: 19285298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial experience of transcatheter arterial chemoembolization during portal vein occlusion for unresectable hepatocellular carcinoma with marked arterioportal shunts.
    Murata S; Tajima H; Nakazawa K; Onozawa S; Kumita S; Nomura K
    Eur Radiol; 2009 Aug; 19(8):2016-23. PubMed ID: 19238387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.